Advertisement
Screener

Catheter Precision, Inc. (VTAK) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

1.8 / 5 stars · 21/60 Roast Me

Catheter Precision, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares.
  • Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was -401.93M shares.
  • Catheter Precision, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 402.33K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
2023-12-31-401.93M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
402.33K shares
10-K · filed 2024-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
NEXGEL, INC. (NXGL)United States$0.002B
Tenon Medical, Inc. (TNON)United States$0.002B
Profusa, Inc. (PFSA)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B